Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Elcriton

2008 FOUNDED
M&A STATUS
1-10 EMPLOYEES
M&A LATEST DEAL TYPE
3 FINANCING ROUNDS
Description

Developer of biochemical technologies. The company is specialized in commercializing of technologies that supplant fossil fuel consumption, reduce green house gas emissions and accelerate the expansion of cleantech industries in the United States.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Other Commercial Services
Other Commercial Products
Acquirer
Primary Office
  • 15 Reads Way
  • Suite 106
  • New Castle, DE 19720
  • United States

Elcriton Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Elcriton‘s full profile, request access.

Request full access to PitchBook

Elcriton Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Elcriton‘s full profile, request access.

Request full access to PitchBook

Elcriton Executive Team (2)

Name Title Board
Seat
Contact
Info
Terry Papoutsakis Ph.D President & Founder
Bryan Tracy Ph.D Chief Executive Officer & Lead Scientist